« Previous
Next »
Gastroenterology
Volume 129, Issue 3
, Pages 995-1004
, September 2005
Inhibition of Transient Lower Esophageal Sphincter Relaxation and Gastroesophageal Reflux by Metabotropic Glutamate Receptor Ligands
References
-
.
GABAB receptors—peripheral and central targets for controlling gastro-oesophageal reflux
.
Curr Opin CPNS Invest Drugs
. 2000;2:333–343
-
.
Systemic pharmacomodulation of transient lower esophageal sphincter relaxations
.
Am J Med
. 2001;111(Suppl 8A):178S–185S
- . Inhibition of transient LES relaxations and reflux in ferrets by GABA receptor agonists . Am J Physiol . 1999;277:G867–G874
- . Mechanisms of gastro-oesophageal reflux in the ferret . Neurogastroenterol Motil . 1998;10:49–56
- . Triggering of transient LES relaxations in ferrets (role of sympathetic pathways and effects of baclofen) . Am J Physiol Gastrointest Liver Physiol . 2000;279:G157–G162
- . Abolition of gas reflux and transient lower esophageal sphincter relaxation by vagal blockade in the dog . Gastroenterology . 1986;91:890–896
- . Transient lower esophageal sphincter relaxation . Gastroenterology . 1995;109:601–610
-
.
GABA(B) receptors inhibit mechanosensitivity of primary afferent endings
.
J Neurosci
. 1999;19:8597–8602
- . GABA(B) receptors on vagal afferent pathways (peripheral and central inhibition) . Am J Physiol Gastrointest Liver Physiol . 2001;280:G658–G668
- . GABA(B)R expressed on vagal afferent neurones inhibit gastric mechanosensitivity in ferret proximal stomach . Am J Physiol Gastrointest Liver Physiol . 2001;281:G1494–G1501
-
.
Receptors and transmission in the brain-gut axis
(potential for novel therapies)
.
IV. GABA(B) receptors in the brain-gastroesophageal axis. Am J Physiol Gastrointest Liver Physiol
. 2001;281:G311–G315
- . Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects . Gastroenterology . 2000;118:7–13
- . Control of transient lower oesophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in patients with gastro-oesophageal reflux disease . Gut . 2002;50:19–24
- . Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs . Gastroenterology . 1999;117:1147–1154
- . Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease . Gut . 2003;52:464–470
- . Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease . Aliment Pharmacol Ther . 2002;16:869–873
- . Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH . Aliment Pharmacol Ther . 2003;17:243–251
- . Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons . Gastroenterology . 2005;128:402–410
- . Receptors and transmission in the brain-gut axis. II. Excitatory amino acid receptors in the brain-gut axis . Am J Physiol Gastrointest Liver Physiol . 2001;280:G1055–G1060
- . Pharmacological agents acting at subtypes of metabotropic glutamate receptors . Neuropharmacology . 1999;38:1431–1476
- . Regulation of neurotransmitter release by metabotropic glutamate receptors . J Neurochem . 2000;75:889–907
- . Systemic administration of the potent mGlu8 receptor agonist (S)-3,4-DCPG induces c-Fos in stress-related brain regions in wild-type, but not mGlu8 receptor knockout mice . Neuropharmacology . 2003;45:473–483
- . Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice . Br J Pharmacol . 2003;140:315–322
- . [(3)H]-M-MPEP, a potent, subtype-selective radioligand for the metabotropic glutamate receptor subtype 5 . Bioorg Med Chem Lett . 2002;12:407–409
- . Anxiolytic-like activity of the mGluR5 antagonist MPEP a comparison with diazepam and buspirone . Pharmacol Biochem Behav . 2002;73:359–366
- 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist . Neuropharmacology . 1999;38:1493–1503
- . [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain (in vitro and in vivo characterization) . J Pharmacol Exp Ther . 2002;303:1044–1051
- . mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors . J Pharmacol Exp Ther . 2001;296:41–47
- . (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord . Neuropharmacology . 2001;40:311–318
-
.
The metabotropic glutamate receptor 5 antagonist MPEP inhibits transient lower esophageal sphincter relaxations in the dog
.
(abstr)
Gastroenterology
. 2004;126:A632
- . Cannabinoid receptor agonism inhibits transient lower esophageal sphincter relaxations and reflux in dogs . Gastroenterology . 2002;123:1129–1134
- . The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease . Aliment Pharmacol Ther . 2002;16:1655–1662
- . Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation . Gastroenterology . 1997;113:409–414
- . Baclofen effects on esophageal function (a possible therapy for GERD?) . Gastroenterology . 2002;123:1736–1737
- . Is glutamate involved in transient lower esophageal sphincter relaxations? . Dig Dis Sci . 2002;47:661–666
- . Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects . Gastroenterology . 1995;109:1547–1554
- . Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans . Gut . 1997;40:575–581
- . Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism . Br J Pharmacol . 2000;131:1429–1437
- . 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity) . J Med Chem . 2003;46:204–206
- . Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor (2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893)) . Neuropharmacology . 2000;39:1567–1574
-
.
Metabotropic glutamate receptors expressed on vagal afferents inhibit mechanosensitivity
.
(abstr)
Gastroenterology
. 2002;122:T921
- . Reduction of excitatory transmission in the retino-collicular pathway via selective activation of mGlu8 receptors by DCPG . Neuropharmacology . 2002;43:231–234
- . Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP . Br J Pharmacol . 2003;138:1026–1030
- . Effects of antagonism of NMDA receptors on transient lower esophageal sphincter relaxations in the dog . Eur J Pharmacol . 2001;431:253–258
- . Peripheral group I metabotropic glutamate receptors modulate nociception in mice . Nat Neurosci . 2001;4:417–423
Supported by AstraZeneca R&D (Mölndal, Sweden).
PII: S0016-5085(05)01357-0
doi: 10.1053/j.gastro.2005.06.069
© 2005 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Gastroenterology
Volume 129, Issue 3
, Pages 995-1004
, September 2005

